ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Airtraq Versus MacIntosh Intubation Via Nasal Approach

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00847184
Recruitment Status : Unknown
Verified February 2009 by Kliniken Essen-Mitte.
Recruitment status was:  Recruiting
First Posted : February 19, 2009
Last Update Posted : February 19, 2009
Sponsor:
Information provided by:
Kliniken Essen-Mitte

Brief Summary:
Time, success rate, and number of optimising maneuvers for tracheal intubation via the nasal approach are not different when Aitraq technique is used compared to a standard MacIntosh blade.

Condition or disease Intervention/treatment Phase
Tracheal Intubation Device: Intubation Device: Airtraq Not Applicable

Detailed Description:
One hundred adult patients with an expected easy intubation and 100 patients with an expected difficult intubation are enrolled. Intubations are performed by two experienced fully boarded anesthesiologists. The design of the study is prospective and randomised.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Comparison of Airtraq vs. MacIntosh Intubation Via Nasal Approach
Study Start Date : February 2009
Estimated Primary Completion Date : November 2009
Estimated Study Completion Date : November 2009

Arm Intervention/treatment
Active Comparator: 1. Airtraq
Intubation with the use of the Airtraq technique
Device: Airtraq
Intubation with the use of the Airtraq technique
Other Name: Aitraq, Prodol Meditec S.A., Vizcaya, Spain
Active Comparator: 2. MacIntosh
Intubation using the standard MacIntosh blade
Device: Intubation
Intubation using the standard MacIntosh blade



Primary Outcome Measures :
  1. Time for intubation [ Time Frame: 10 month ]

Secondary Outcome Measures :
  1. Success rate for intubation [ Time Frame: 10 month ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Scheduled for nasal intubation
  • Adult

Exclusion Criteria:

  • Age under 18 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00847184


Locations
Germany
Prof. Dr. Harald Groeben Recruiting
Essen, Germany, 45136
Contact: Harald Groeben, M.D.    ##49 201 174 31109    h.groeben@kliniken-essen-mitte.de   
Principal Investigator: Harald Groeben, M.D.         
Sponsors and Collaborators
Kliniken Essen-Mitte
Investigators
Principal Investigator: Harald Groeben, M.D. Kliniken Essen-Mitte

Publications:
Responsible Party: Prof. Dr. Harald Groeben, Kliniken Essen-Mitte
ClinicalTrials.gov Identifier: NCT00847184     History of Changes
Other Study ID Numbers: Airtraqnasal2009
First Posted: February 19, 2009    Key Record Dates
Last Update Posted: February 19, 2009
Last Verified: February 2009

Keywords provided by Kliniken Essen-Mitte:
nasal intubation
Aitraq
difficult intubation